Anti-Human DIABLO Antibody [A1185]
Anti-Human DIABLO Antibody [A1185] with collaborator-tested evidence for WB, Flow Cyt, ICC/IF. Read more ›
["WBProduct Description
DIABLO is the stated target for this antibody product. The listing uses collaborator-supplied technical data from Elabscience and is structured for research-use-only antibody selection through ABMIUM.
Product profile: reactivity: Human; host: Rabbit; clonality: Monoclonal; clone: A1185; isotype: IgG; available conjugation options: Unconjugated.
Application evidence: Elabscience lists this product for WB, FCM, ICC/IF. In the ABMIUM matrix, these listed applications are marked C to show collaborator-tested ABMIUM Verified evidence. Applications not listed in the supplied data remain marked N.
Technical notes: immunogen: Recombinant Human SMAC / Diablo protein; purification: Protein A; concentration: 1 mg/mL.
Database references: UniProt: Q9NR28 | NCBI Gene: 56616.
Research Use Only.
Key Facts
| Target | DIABLO |
| Also known as | DFNA, DIABLO, DFNA64, SMAC, 0610041G12Rik, DBLOH, DBOH, Diablo homolog, Diablo homolog (Drosophila), Diablo homolog mitochondrial, Diablo IAP binding mitochondrial protein, Diablo like protein, DIABLO S, Direct IAP binding protein with low pI, Direct IAP-binding protein with low pI, FLJ10537, FLJ25049, mitochondrial, Mitochondrial Smac protein, Second mitochondria derived activator of caspase, Second mitochondria-derived activator of caspase, SMAC 3, Smac protein, SMAC3 |
| Concentration | 1 mg/mL |
| Species reactivity | Human |
| Observed band | 20 kDa |
| Shelf life | 12 months from shipping dates |
| Research area | Cell Biology, Cancer, Metabolism |
| WB | IHC-P | IHC-FR | IF/ICC | FLOW CYT | IP | CHIP | ICC/IF | |
|---|---|---|---|---|---|---|---|---|
| Human |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.